Elizabeth A. Sugar

Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

Maura L. Gillison, Gypsyamber DʼSouza, William H. Westra et al. · JNCI Journal of the National Cancer Institute · 2008 · 1.5K citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Richard E. Thompson, Michael Rosenblum, Gayane Yenokyan et al. · The Lancet · 2019 · 899 citations · Full text

Medicine, Neurosurgery, Surgery +15

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

Dung T. Le, Eric R. Lutz, Jennifer N. Uram et al. · Journal of Immunotherapy · 2013 · 554 citations

Medicine, Oncology, Pharmacology +17

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Joseph M. Herman, Daniel T. Chang, Karyn A. Goodman et al. · Cancer · 2014 · 538 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial

Daniel F. Hanley, Karen Lane, Nichol McBee et al. · The Lancet · 2017 · 488 citations · Full text

Medicine, Neurology, Cerebrovascular Neurosurgery +12